Explore Watchlists Pricing

PhoenixBio Co.,Ltd. (6190) Income statement

Market cap

¥1.5B

P/E ratio

19.6x

Phoenix Bio provides pharmaceutical testing services using PXB mice with human liver cells to help drug companies predict how medicines work in people.

Summary Financials Dividends History Ownership Workforce

Income statement Balance sheet Cash flow Other

	2012/03	2013/03	2014/03	2015/03	2016/03	2017/03	2018/03	2019/03	2020/03	2021/03	2022/03	2023/03	2024/03	2025/03	2026/03
Revenue	794	980	1,153	881	1,217	1,229	902	1,228	1,311	1,014	1,325	2,124	1,715	1,541	1,565
Revenue growth (%)	-
Cost of revenue	-	-	-	268	388	389	397	377	445	425	597	568	520	424	365
Gross profit	-	-	-	613	829	840	506	851	866	588	728	1,556	1,195	1,118	1,201
Gross margin (%)	-	-	-
Operating margin (%)	-	-	-
Operating expenses	-	-	-	563	638	698	774	1,163	1,013	865	895	1,048	1,184	1,260	1,118
Operating income	-	-	-	51	190	142	-269	-312	-147	-277	-168	508	11	-142	82
Income before tax	-237	-60	51	63	149	133	-267	-280	-125	-224	-128	511	44	-155	131
Pretax margin (%)	-29.9	-6.1	4.4	7.1	12.3	10.8	-29.6	-22.8	-9.6	-22.1	-9.7	24.1	2.5	-10.1	8.4
Provision for income taxes	-	-	-	6	22	2	3	2	-2	14	-5	17	33	16	6
Effective tax rate (%)	-	-	-
Net income	-240	-62	144	57	125	128	-271	-297	-416	-238	-388	493	26	-449	175
Earnings per share	-12.29	-2.91	51.63	22.72	49.32	44.43	-93.36	-101.96	-141.84	-73.6	-117.5	145.23	6.98	-110.99	30.81
Diluted EPS	-	-	-	-	48.42	44.17	-	-	-	-	-	97.29	-	-	-
Dividend payout ratio (%)	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Dividend per share	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-